Multidrug resistance and the role of P-glycoprotein knockout mice
- 31 August 1995
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 31 (7), 1295-1298
- https://doi.org/10.1016/0959-8049(95)00130-b
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Clinical reversal of the multidrug resistance phenotype: True tumour modulation or pharmacokinetic interaction?European Journal of Cancer, 1994
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for NeuroblastomaThe New England Journal of Medicine, 1991
- Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas.Molecular and Cellular Biology, 1990
- Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.Molecular and Cellular Biology, 1990
- Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cellsPublished by Elsevier BV ,1989
- The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.Molecular and Cellular Biology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989